Atıf İçin Kopyala
Ding W. Y., Boriani G., Marin F., Blomström-Lundqvist C., Potpara T. S., Fauchier L., ...Daha Fazla
European heart journal. Cardiovascular pharmacotherapy, cilt.8, ss.372-382, 2022 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
8
-
Basım Tarihi:
2022
-
Doi Numarası:
10.1093/ehjcvp/pvab076
-
Dergi Adı:
European heart journal. Cardiovascular pharmacotherapy
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
-
Sayfa Sayıları:
ss.372-382
-
Anahtar Kelimeler:
Atrial fibrillation, Digoxin, Beta blocker, Rate control, Mortality, Hospitalizations, Quality of life, Permanent AF, Heart failure, CKD, EORP-AF, Registry, HEART-FAILURE, INCREASED MORTALITY, RISK, METAANALYSIS, GUIDELINES, MANAGEMENT, EFFICACY, STROKE
-
Hacettepe Üniversitesi Adresli:
Evet
Özet
Aims The safety of digoxin therapy in atrial fibrillation (AF) remains ill-defined. We aimed to evaluate the effects of digoxin over beta-blocker therapy in AF.